Koyfin Home > Directory > Health Care > Akebia Therapeutics > Net Income

Akebia Therapeutics Net Income Chart (AKBA)

Akebia Therapeutics annual/quarterly Net Income from 2012 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Akebia Therapeutics Net Income for the quarter ending June 06, 2020 was $-176m a 68.94% decrease of -121m year over year
  • Akebia Therapeutics Net Income for the last 12 months ending June 06, 2020 was $-386m a 36.40% decrease of -140m year over year
  • Akebia Therapeutics Annual Net Income for 2019 was $-280m a 48.66% decrease of -136m from 2018
  • Akebia Therapeutics Annual Net Income for 2018 was $-144m a 48.69% decrease of -70m from 2017
  • Akebia Therapeutics Annual Net Income for 2017 was $-74m a -84.26% increase of 62m from 2016
Other Income Statement Metrics:
  • Akebia Therapeutics EBITDA for the quarter ending December 12, 2018 was $-85m a 71.45% decrease of -61m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Net Income Data

06/2020$-176m
03/2020$-61m
12/2019$-94m
09/2019$-55m
06/2019$-58m
03/2019$-72m
12/2018$-60m
09/2018$-26m
06/2018$-34m
03/2018$-23m

Annual AKBA Net Income Data

2019$-280m
2018$-144m
2017$-74m
2016$-136m
2015$-61m
2014$-37m
2013$-13m
2012$-8m
2011$-15m